Ethics Government Healthcare Training 
Nixon Gwilt Law
APRIL 22, 2024
That said, the flurry of regulatory policymaking and legislation, congressional hearings and inquiries, and industry stakeholder organization around the development and deployment of healthcare AI portends major developments in the coming years. HIPAA is the pantheon of healthcare data privacy regulation in the U.S. HIPAA What is it?
Pharma Marketing Network
MAY 6, 2023
While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination. “The ethics of artificial intelligence.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rep-Lite
APRIL 4, 2024
Sales representatives play a crucial role in connecting healthcare facilities with innovative technologies that improve patient care. While the rewards can be significant, carving a successful path in this field requires a unique blend of technical knowledge, interpersonal skills, and a commitment to ethical practices.
European Pharmaceutical Review
MARCH 12, 2024
Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. Training and education.
Pharma Marketing Network
DECEMBER 17, 2021
Companies are invited to reapply each year to be evaluated based on how their policies, actions, and results are impacting the environment, ethics, labor and human rights, and sustainable procurement. And last, but certainly not least—governance. Ethics is a skill.” Social impact is also high on the list. Why make it inviting?
Pharma Marketing Network
JULY 26, 2023
As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. The post Why Is FDA Issuing Fewer Marketing Violation Letters?
Nixon Gwilt Law
FEBRUARY 23, 2024
Nixon Gwilt Law (NGL) is excited to announce a significant expansion of our core capabilities through the addition of four attorneys with expertise in healthcare mergers and acquisitions , fundraising and venture capital , and corporate/business counsel. William added, “NGL is leading the way in serving healthcare innovators.
Expert insights. Personalized for you.
52 
Let's personalize your content